QCompany · Healthtech & Bio
Quibim
Quibim builds AI foundation models and imaging biomarker software that extract quantitative, whole-body insights from MRI, CT, PET and X-ray scans, sold as a SaaS platform to hospitals and as a co-development partner to pharma/life-sciences companies (oncology, neurology, immunology, metabolic disease). Founded as a spin-off of La Fe Health Research Institute in Valencia, it raised a $50M Series A in January 2025 (~$70M total) led by Asabys Partners and Buenavista, has ~90+ staff across Valencia, Madrid, Barcelona, New York, Dallas and Cambridge (UK), and its flagship QP-Prostate product is used by 170+ healthcare institutions, with partnerships including Philips and Merck KGaA.
Founded
2012
Founders
2
News
10
Rounds
2
Investors
13
SectorsHealthtech & Bio, AI & Data, Medical Imaging, Medtech, SaaS
Start-up MapHealthtech & Bio › Diagnostics & precision medicine testing
Profile updated 15 Aug 2026
Founders
L
Luis Martí-Bonmatí
Co-founder
Á
Ángel Alberich-Bayarri
Co-founder & CEO
Global models
No comparables on record yet.
Investors 13
AAdara Ventures
www.adara.vc
AAmadeus Capital Partners
AAngels Capital
www.angelscapital.es
AAPEX Ventures
AAsabys Partners
asabys.com
BBuenavista Equity Partners
buenavistaequity.com
CCDTI Innovación
www.cdti.es
CClave Capital (Tech Transfer UPV)
clavemayor.com
CCrista Galli Ventures
GGoHub Ventures
gohub.vc
KK Fund (Leadwind)
www.kfund.vc
PPartech
UUI Investissements